Identification of Drug Combination Therapies for SARS-CoV-2: A Molecular Dynamics Simulations Approach
Article
[키워드] 3CL
antiviral activity
Antiviral treatment
approved
approved drug
binding
binding site
carried
caused
Compound
compounds
conformational change
coronavirus
COVID-19
drug
drug combination
drug combinations
Drug repurposing
drug synergy
Dynamics
effective
Efficacy
enzyme
Favipiravir
identification
in silico
in vitro
in vitro assays
Infectious disease
inhibitor
inhibitory effect
Ligand
ligand docking
M pro
molecular
Molecular dynamics simulation
molecular dynamics simulations
multiple binding sites.
pandemic
predicted
protease
Protein target
Proteins
provide
reduced
SARS-CoV-2
SARS-CoV-2 viral
screened
Simulation
suggested
synergism
synergistic
Toxicity
Treatment
treatments for COVID-19
virus
[DOI] 10.2147/DDDT.S366423 PMC 바로가기
[DOI] 10.2147/DDDT.S366423 PMC 바로가기